---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-103024"
form_type: "8-K"
ticker: "HNGE"
cik: "0001673743"
company_name: "Hinge Health, Inc."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:47:39.198547+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Hinge Health Q2 revenue $139.1M (+55% YoY); non-GAAP operating income $26.1M; guides FY revenue $548-552M

## Summary
- Revenue grew 55% YoY to $139.1M; GAAP gross margin 70%, non-GAAP gross margin 83%.
- GAAP loss from ops $580.7M (incl $591M stock-based comp); non-GAAP income from ops $26.1M vs loss $14.4M.
- Free cash flow $32.6M (incl $14.2M IPO tax adjustment) vs $14.0M; cash $415.1M.
- Clients up 32% to 2,359; LTM calculated billings $568.4M, +55% YoY.
- Q3 rev guidance $141-143M (41% YoY growth); FY rev guidance $548-552M (41% YoY growth).

## SEC filing metadata
- accession: 0000950170-25-103024
- form_type: 8-K
- ticker: HNGE
- cik: 0001673743
- company_name: Hinge Health, Inc.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1673743/000095017025103024/0000950170-25-103024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1673743/000095017025103024/hnge-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-103024
- JSON: https://secwatch.observer/filing/0000950170-25-103024.json
- Plain text: https://secwatch.observer/filing/0000950170-25-103024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.